🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

DigiPall; a Trial of Digital Patient Reported Outcome and Biomarker Monitoring in Palliative Care

RecruitingNAAges 18 Years - anyAllDavid Blum
NCT06615349 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The aim of this study is to test if a system consisting of a wearable device measuring heartbeats and steps, together with daily communication with a chatbot on the smartphone asking the patients about their symptoms and giving tips, can reduce unplanned hospital readmissions and improve well-being in advanced cancer and severely ill patients.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Patients with established diagnosis of a metastatic cancer/severe illness with limited life expectancy receiving palliative care services * Estimated life expectancy \<24 months (physician's guess)/ \>3 months * Karnofsky Index ≥ 50% / ECOG≤ 2 * Aged \>18 years * Owns and uses a smartphone * Give written informed consent Exclusion Criteria: * Patients under curative treatment * Relevant cognitive impairment
💊

What it tests

  • DigiPall
📍

Where

1 site
University Hospital Zurich
Zurich, Switzerland
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy